Last reviewed · How we verify
NCT06830226: DompMilk
Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer
trial testing Test group in Insufficient Breast Milk Syndrome in 81 participants. Enrolling by invitation.
30 July 2025
Quick facts
| Lead sponsor | Centro Hospitalar de Lisboa Central |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 81 |
| Start date | 8 January 2025 |
| Primary completion | 30 July 2025 |
| Estimated completion | 30 August 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Test group
- Reference group
Conditions studied
- Insufficient Breast Milk Syndrome — all drugs for Insufficient Breast Milk Syndrome →
- Premature Birth — all drugs for Premature Birth →
Sponsor
Centro Hospitalar de Lisboa Central
Who can join
Eligibility, female only, with Insufficient Breast Milk Syndrome or Premature Birth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Maintaining milk production in lactating mothers who have delivered prematurely can be a challenge. In these cases, domperidone has been the most commonly used pharmacologic galactagogue. There are several studies on the effect of this drug on the volume of milk produced, but data on its effect on the macronutrient and energy content is scarce. The mid-infrared spectroscopy is a convenient validated method to assess human milk macronutrient and energy content because it requires little training for its operation and a small volume of milk. This study aims to determine the effect of domperidone on the macronutrient and energy content of milk from women who have delivered prematurely, and to compare the results obtained with those reported using reference methods for this analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06830226
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Test group
Trials testing the same drug.
- NCT06218537 — The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy · NA · completed
- NCT06168500 — Narrow Implants Vs Standard Implants With Simultaneous GBR · NA · completed
- NCT03804281 — Clinical Evaluation of Conventional Versus Microsurgical Techniques of Esthetic Crown Lengthening · NA · unknown
- NCT04074915 — Effects of Herbal Mouth Rinse for Chronic Periodontitis · NA · completed
- NCT03641365 — Sleeves Versus Sleeveless Template · NA · completed
Other Centro Hospitalar de Lisboa Central trials
Trials by the same sponsor.
- NCT07483424 — Determination of Clinical Phenotypes of Intrauterine Growth Restriction in Term Infants Based on Body Composition · enrolling by invitation
- NCT06839443 — Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy · recruiting
- NCT06094309 — Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease. · NA · unknown
- NCT06044480 — Effect of Dexamethason on Postimplantation Syndrome After EVAR · Phase 4 · not yet recruiting
- NCT04762992 — LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth) · Phase 3 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06830226 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar de Lisboa Central
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06830226.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing